Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes
- PMID: 19915563
- PMCID: PMC2797836
- DOI: 10.1038/nn.2447
Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes
Abstract
Cortical GABAergic dysfunction may underlie the pathophysiology of psychiatric disorders, including schizophrenia. Here, we characterized a mouse strain in which the essential NR1 subunit of the NMDA receptor (NMDAR) was selectively eliminated in 40-50% of cortical and hippocampal interneurons in early postnatal development. Consistent with the NMDAR hypofunction theory of schizophrenia, distinct schizophrenia-related symptoms emerged after adolescence, including novelty-induced hyperlocomotion, mating and nest-building deficits, as well as anhedonia-like and anxiety-like behaviors. Many of these behaviors were exacerbated by social isolation stress. Social memory, spatial working memory and prepulse inhibition were also impaired. Reduced expression of glutamic acid decarboxylase 67 and parvalbumin was accompanied by disinhibition of cortical excitatory neurons and reduced neuronal synchrony. Postadolescent deletion of NR1 did not result in such abnormalities. These findings suggest that early postnatal inhibition of NMDAR activity in corticolimbic GABAergic interneurons contributes to the pathophysiology of schizophrenia-related disorders.
Figures







Comment in
-
Testing the glutamate hypothesis of schizophrenia.Nat Neurosci. 2010 Jan;13(1):2-4. doi: 10.1038/nn0110-2. Nat Neurosci. 2010. PMID: 20033077 No abstract available.
References
-
- Lodge D, Anis NA. Effects of phencyclidine on excitatory amino acid activation of spinal interneurones in the cat. Eur J Pharmacol. 1982;77:203–204. - PubMed
-
- Javitt DC. Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia. Hillside J Clin Psychiatry. 1987;9:12–35. - PubMed
-
- Olney JW. In: Excitatory Acid Acids in Health and Disease. Lodge D, editor. Wiley; London: 1988. pp. 337–351.
-
- Deutsch SI, Mastropaolo J, Schwartz BL, Rosse RB, Morihisa JMA. “glutamatergic hypothesis” of schizophrenia. Rationale for pharmacotherapy with glycine. Clin Neuropharmacol. 1989;12:1–13. - PubMed
-
- Krystal JH, et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry. 1994;51:199–214. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials